Polymorphism of LRP5 gene and emphysema severity are associated with osteoporosis in Japanese patients with or at risk for COPD

Respirology

Volumn 20, Issue 2, 2015, Pages 286-295

  Chubachi, Shotaro ^a   Nakamura, Hidetoshi ^a,b   Sasaki, Mamoru ^a   Haraguchi, Mizuha ^a   Miyazaki, Masaki ^a   Takahashi, Saeko ^a   Tanaka, Kyuto ^a   Funatsu, Yohei ^a   Asano, Koichiro ^c   Betsuyaku, Tomoko ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

bone mineral density; chronic obstructive pulmonary disease; genetic polymorphism; low density lipoprotein receptor related protein 5; osteoporosis

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; LRP5 PROTEIN, HUMAN;

AGED; ARTICLE; BONE DENSITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FRACTURE; GENETIC POLYMORPHISM; GENOTYPE; HIP; HUMAN; JAPANESE (PEOPLE); LUMBAR SPINE; LUNG EMPHYSEMA; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OSTEOPOROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SPINE FRACTURE; ASIAN CONTINENTAL ANCESTRY GROUP; COMORBIDITY; GENETICS; JAPAN; MIDDLE AGED; PHENOTYPE; PROSPECTIVE STUDY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; RADIOGRAPHY; RISK FACTOR; SEX DIFFERENCE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BONE DENSITY; COMORBIDITY; FEMALE; GENOTYPE; HUMANS; JAPAN; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-5; MALE; MIDDLE AGED; OSTEOPOROSIS; PHENOTYPE; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; RISK FACTORS; SEX FACTORS;

EID: 84921503307     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12429     Document Type: Article

References (42)

1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, et al. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 2007; 176: 532-555.
2. Divo M, Cote C, de Torres JP, Casanova C, Marin JM, Pinto-Plata V, Zulueta J, Cabrera C, Zagaceta J, Hunninghake G, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2012; 186: 155-161.
3. Ferguson GT, Calverley PM, Anderson JA, Jenkins CR, Jones PW, Willits LR, Yates JC, Vestbo J, Celli B,. Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study. Chest 2009; 136: 1456-1465.
4. Duckers JM, Evans BA, Fraser WD, Stone MD, Bolton CE, Shale DJ,. Low bone mineral density in men with chronic obstructive pulmonary disease. Respir. Res. 2011; 12: 101.
5. Slemenda CW, Christian JC, Reed T, Reister TK, Williams CJ, Johnston CC Jr,. Long-term bone loss in men: effects of genetic and environmental factors. Ann. Intern. Med. 1992; 117: 286-291.
6. Lehouck A, Boonen S, Decramer M, Janssens W,. COPD, bone metabolism, and osteoporosis. Chest 2011; 139: 648-657.
7. Kjensli A, Mowinckel P, Ryg MS, Falch JA,. Low bone mineral density is related to severity of chronic obstructive pulmonary disease. Bone 2007; 40: 493-497.
8. Ohara T, Hirai T, Muro S, Haruna A, Terada K, Kinose D, Marumo S, Ogawa E, Hoshino Y, Niimi A, et al. Relationship between pulmonary emphysema and osteoporosis assessed by CT in patients with COPD. Chest 2008; 134: 1244-1249.
9. Bon J, Fuhrman CR, Weissfeld JL, Duncan SR, Branch RA, Chang CC, Zhang Y, Leader JK, Gur D, Greenspan SL, et al. Radiographic emphysema predicts low bone mineral density in a tobacco-exposed cohort. Am. J. Respir. Crit. Care Med. 2011; 183: 885-890.
10. Hardy R, Cooper MS,. Bone loss in inflammatory disorders. J. Endocrinol. 2009; 201: 309-320.
11. Mundy GR,. Osteoporosis and inflammation. Nutr. Rev. 2007; 65: S147-151.
12. Gallagher JC,. Advances in bone biology and new treatments for bone loss. Maturitas 2008; 60: 65-69.
13. Bai P, Sun Y, Jin J, Hou J, Li R, Zhang Q, Wang Y,. Disturbance of the OPG/RANK/RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosis. Respir. Res. 2011; 12: 157.
14. Raisz LG,. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J. Clin. Invest. 2005; 115: 3318-3325.
15. Koay MA, Brown MA,. Genetic disorders of the LRP5-Wnt signalling pathway affecting the skeleton. Trends Mol. Med. 2005; 11: 129-137.
16. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 2001; 107: 513-523.
17. Richards JB, Rivadeneira F, Inouye M, Pastinen TM, Soranzo N, Wilson SG, Andrew T, Falchi M, Gwilliam R, Ahmadi KR, et al. Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet 2008; 371: 1505-1512.
18. van Meurs JB, Trikalinos TA, Ralston SH, Balcells S, Brandi ML, Brixen K, Kiel DP, Langdahl BL, Lips P, Ljunggren O, et al. Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. JAMA 2008; 299: 1277-1290.
19. Grundberg E, Lau EM, Lorentzon M, Karlsson M, Holmberg A, Groop L, Mellström D, Orwoll E, Mallmin H, Ohlsson C, et al. Large-scale association study between two coding LRP5 gene polymorphisms and bone phenotypes and fractures in men. Osteoporos. Int. 2008; 19: 829-837.
20. Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, Fabbri LM, Goldin JG, Jones PW, Macnee W, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am. J. Respir. Crit. Care Med. 2010; 182: 598-604.
21. Miyazaki M, Nakamura H, Chubachi S, Sasaki M, Haraguchi M, Yoshida S, Tsuduki K, Shirahata T, Takahashi S, Minematsu N, et al. The Keio COPD Comorbidity Research (K-CCR) Group. Analysis of comorbid factors that increase the COPD assessment test scores. Respir. Res. 2014; 15: 13.
22. Nishimura M, Aizawa H, Kanbe M, Kimura H, Sakakibara H, Sato H, Suga Y, Tojo N, Hida W, Miyamoto K, et al,. Committee of Pulmonary Physiology, the Japanese Respiratory Society Guidelines for Pulmonary Function Tests: Spirometry, Flow-volume Curve, Diffusion Capacity of the Lung. Japanese Respiratory Society, Tokyo, 2004.
23. Biskobing DM,. COPD and osteoporosis. Chest 2002; 121: 609-620.
24. Barrett-Connor E, Black D, Bonjour JP, Dequeker J, Ehrlich GE, Eis SR, Genant HK, Gennari C, Johnell O, Kanis J, et al,. Prevention and management of osteoporosis. World Health Organ. Tech. Rep. Ser. 2003; 921: 1-164.
25. Genant HK, Wu CY, van Kuijk C, Nevitt MC,. Vertebral fracture assessment using semiquantitative technique. J. Bone Miner. Res. 1993; 8: 1137-1148.
26. Knudsen ST, Foss CH, Poulsen PL, Andersen NH, Mogensen CE, Rasmussen LM,. Increased plasma concentrations of osteoprotegerin in type 2 diabetic patients with microvascular complications. Eur. J. Endocrinol. 2003; 149: 39-42.
27. Newell JD Jr, Sieren J, Hoffman EA,. Development of quantitative computed tomography lung protocols. J. Thorac. Imaging 2013; 28: 266-271.
28. Mishima M, Hirai T, Jin Z, Oku Y, Sakai N, Nakano Y, Sakai H, Chin K, Ohi M, Kawakami K, et al. Standardization of low attenuation area versus total lung area in chest X-ray CT as an indicator of chronic pulmonary emphysema. Front. Med. Biol. Eng. 1997; 8: 79-86.
29. Park KJ, Bergin CJ, Clausen JL,. Quantitation of emphysema with three-dimensional CT densitometry: comparison with two-dimensional analysis, visual emphysema scores, and pulmonary function test results. Radiology 1999; 211: 541-547.
30. Nishimura M, Makita H, Nagai K, Konno S, Nasuhara Y, Hasegawa M, Shimizu K, Betsuyaku T, Ito YM, Fuke S, et al. Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2012; 185: 44-52.
31. Nakano Y, Muro S, Sakai H, Hirai T, Chin K, Tsukino M, Nishimura K, Itoh H, Paré PD, Hogg JC, et al. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am. J. Respir. Crit. Care Med. 2000; 162: 1102-1108.
32. Ezura Y, Nakajima T, Urano T, Sudo Y, Kajita M, Yoshida H, Suzuki T, Hosoi T, Inoue S, Shiraki M, et al. Association of a single-nucleotide variation (A1330V) in the low-density lipoprotein receptor-related protein 5 gene (LRP5) with bone mineral density in adult Japanese women. Bone 2007; 40: 997-1005.
33. Ogura-Tomomatsu H, Asano K, Tomomatsu K, Miyata J, Ohmori N, Kodama M, Ueda S, Takihara T, Tanaka K, Kamiishi N, et al. Predictors of osteoporosis and vertebral fractures in patients presenting with moderate-to-severe chronic obstructive lung disease. COPD 2012; 9: 332-337.
34. van Meurs JB, Rivadeneira F, Jhamai M, Hugens W, Hofman A, van Leeuwen JP, Pols HA, Uitterlinden AG,. Common genetic variation of the low-density lipoprotein receptor-related protein 5 and 6 genes determines fracture risk in elderly white men. J. Bone Miner. Res. 2006; 21: 141-150.
35. Makita H, Nasuhara Y, Nagai K, Ito Y, Hasegawa M, Betsuyaku T, Onodera Y, Hizawa N, Nishimura M, Hokkaido COPD Cohort Study Group. Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease. Thorax 2007; 62: 932-937.
36. Betsuyaku T, Nishimura M, Takeyabu K, Tanino M, Miyamoto K, Kawakami Y,. Decline in FEV(1) in community-based older volunteers with higher levels of neutrophil elastase in bronchoalveolar lavage fluid. Respiration 2000; 67: 261-267.
37. Brito-Mutunayagam R, Appleton SL, Wilson DH, Ruffin RE, Adams RJ, North West, Adelaide Cohort Health Study Team. Global Initiative for Chronic Obstructive Lung Disease stage 0 is associated with excess FEV(1) decline in a representative population sample. Chest 2010; 138: 605-613.
38. Johnston CC Jr, Slemenda CW, Melton LJ 3rd., Clinical use of bone densitometry. N. Engl. J. Med. 1991; 324: 1105-1109.
39. Graat-Verboom L, Spruit MA, van den Borne BE, Smeenk FW, Wouters EF,. Whole-body versus local DXA-scan for the diagnosis of osteoporosis in COPD patients. J. Osteoporos. 2010; 2010: 640878.
40. Jergas M, Breitenseher M, Glüer CC, Yu W, Genant HK,. Estimates of volumetric bone density from projectional measurements improve the discriminatory capability of dual X-ray absorptiometry. J. Bone Miner. Res. 1995; 10: 1101-1110.
41. Graat-Verboom L, van den Borne BE, Smeenk FW, Spruit MA, Wouters EF,. Osteoporosis in COPD outpatients based on bone mineral density and vertebral fractures. J. Bone Miner. Res. 2011; 26: 561-568.
42. Fujiwara S, Kasagi F, Masunari N, Naito K, Suzuki G, Fukunaga M,. Fracture prediction from bone mineral density in Japanese men and women. J. Bone Miner. Res. 2003; 18: 1547-1553.